715 related articles for article (PubMed ID: 29451472)
21. Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis.
Shu T; Jing C; Lv Z; Xie Y; Xu J; Wu J
Eur J Haematol; 2015 Jan; 94(1):67-73. PubMed ID: 24954786
[TBL] [Abstract][Full Text] [Related]
22. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.
Tandara L; Grubisic TZ; Ivan G; Jurisic Z; Tandara M; Gugo K; Mladinov S; Salamunic I
Clin Biochem; 2015 Dec; 48(18):1252-7. PubMed ID: 26164540
[TBL] [Abstract][Full Text] [Related]
23. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
[TBL] [Abstract][Full Text] [Related]
24. Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease.
Martinelli M; Strisciuglio C; Alessandrella A; Rossi F; Auricchio R; Campostrini N; Girelli D; Nobili B; Staiano A; Perrotta S; Miele E
J Crohns Colitis; 2016 May; 10(5):566-74. PubMed ID: 26733407
[TBL] [Abstract][Full Text] [Related]
25. Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance.
Lee SW; Kim JM; Lim HJ; Hwang YH; Kim SW; Chung W; Oh KH; Ahn C; Lee KB; Sung SA
Sci Rep; 2017 Jun; 7(1):4260. PubMed ID: 28652624
[TBL] [Abstract][Full Text] [Related]
26. The association of hepcidin, reticulocyte hemoglobin equivalent and anemia-related indicators on anemia in chronic kidney disease.
Gao Z; Hu Y; Gao Y; Ma X; Hu Z
Medicine (Baltimore); 2023 Apr; 102(17):e33558. PubMed ID: 37115087
[TBL] [Abstract][Full Text] [Related]
27. Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort.
Atkinson MA; Kim JY; Roy CN; Warady BA; White CT; Furth SL
Pediatr Nephrol; 2015 Apr; 30(4):635-43. PubMed ID: 25380788
[TBL] [Abstract][Full Text] [Related]
28. Serum Hepcidin in Children with Inflammatory Bowel Disease.
Krawiec P; Mroczkowska-Juchkiewicz A; Pac-Kożuchowska E
Inflamm Bowel Dis; 2017 Dec; 23(12):2165-2171. PubMed ID: 28945637
[TBL] [Abstract][Full Text] [Related]
29. Physical exercise intervention at school improved hepcidin, inflammation, and iron metabolism in overweight and obese children and adolescents.
Coimbra S; Catarino C; Nascimento H; Inês Alves A; Filipa Medeiros A; Bronze-da-Rocha E; Costa E; Rocha-Pereira P; Aires L; Seabra A; Mota J; Ferreira Mansilha H; Rêgo C; Santos-Silva A; Belo L
Pediatr Res; 2017 Nov; 82(5):781-788. PubMed ID: 28604755
[TBL] [Abstract][Full Text] [Related]
30. Serum hepcidin levels in Helicobacter pylori-infected children with iron-deficiency anemia: a case-control study.
Azab SF; Esh AM
Ann Hematol; 2013 Nov; 92(11):1477-83. PubMed ID: 23760782
[TBL] [Abstract][Full Text] [Related]
31. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.
Yılmaz I; Ozkok A; Kostek O; Kolukısa A; Duran I; Odabaş AR; Kemal Işman F; Işbilen Başok B
Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647
[TBL] [Abstract][Full Text] [Related]
32. Anemia and low-grade inflammation in pediatric kidney transplant recipients.
Miettinen J; Tainio J; Jahnukainen T; Pakarinen M; Lauronen J; Jalanko H
Pediatr Nephrol; 2017 Feb; 32(2):347-358. PubMed ID: 27576676
[TBL] [Abstract][Full Text] [Related]
33. Iron homeostasis and serum hepcidin-25 levels in obese children and adolescents: relation to body mass index.
Hamza RT; Hamed AI; Kharshoum RR
Horm Res Paediatr; 2013; 80(1):11-7. PubMed ID: 23817203
[TBL] [Abstract][Full Text] [Related]
34. Etiological spectrum of anemia in non-dialysis-dependent chronic kidney disease: A single-center study from India.
Vikrant S
Saudi J Kidney Dis Transpl; 2019; 30(4):932-942. PubMed ID: 31464252
[TBL] [Abstract][Full Text] [Related]
35. [Risk factors for anemia in the early stages of chronic kidney disease].
Milovanov YS; Kozlovskaya LV; Milovanova LY; Markina MM; Kozlov VV; Taranova MV; Fomin VV
Ter Arkh; 2017; 89(6):41-47. PubMed ID: 28745688
[TBL] [Abstract][Full Text] [Related]
36. Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose.
Drakou A; Margeli A; Theodorakopoulou S; Agrogiannis I; Poziopoulos C; Papassotiriou I; Vlahakos DV
Blood Cells Mol Dis; 2016 Jul; 59():100-5. PubMed ID: 27282576
[TBL] [Abstract][Full Text] [Related]
37. Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.
Wagner M; Ashby DR; Kurtz C; Alam A; Busbridge M; Raff U; Zimmermann J; Heuschmann PU; Wanner C; Schramm L
PLoS One; 2015; 10(4):e0123072. PubMed ID: 25894587
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment.
Emans ME; Braam B; Diepenbroek A; van der Putten K; Cramer MJ; Wielders JP; Swinkels DW; Doevendans PA; Gaillard CA
Kidney Blood Press Res; 2012; 36(1):344-54. PubMed ID: 23235391
[TBL] [Abstract][Full Text] [Related]
39. Hepcidin levels in children with chronic liver disease.
Cakir M; Erduran E; Turkmen ES; Aliyazicioglu Y; Reis GP; Cobanoglu U; Demir S
Saudi J Gastroenterol; 2015; 21(5):300-5. PubMed ID: 26458857
[TBL] [Abstract][Full Text] [Related]
40. Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
Gummer J; Trengove R; Pascoe EM; Badve SV; Cass A; Clarke P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; Olynyk JK; Ferrari P;
Nephrology (Carlton); 2017 Jul; 22(7):548-554. PubMed ID: 27171136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
